Replies to post #7410 on Avid Bioservices Inc (CDMO)

[technicalwin]

Katie, they are not done with P1 trial for cancer. Per KING who has seen the raw data, "We believe Bavi has the potential to be a major cancer drug." Per King, it is tough to get patients to do the work. Reason to go to India. Per King, he has clinical programs that have the ability to really steamroll momentum. I have always said the viral will lead the cancer for Bavi. That's my story and I'm sticking to it. These lousy stinking options on top of a financing in a crummy market, explains a lot of our PPS. Looks like Kings strategy is to keep rights in US and license the rest of the world. Can't come soon enough. TW